A study that used a specialized type of magnetic resonance imaging (MRI), named neuromelanin-sensitive MRI, showed that this type of MRI signal was increased in regions of the midbrain in young adults ages 20 to 24 who had an extensive alcohol and drug use history. The findings are published early online in the American Journal of Psychiatry.
Tag: Neurological Disease
Black stroke patients arrive later to hospitals, EMS less likely to notify
During a stroke, Black Americans arrive later to emergency departments — which are less likely to be notified of a patient’s condition ahead of time, a national study shows. Researchers say quality improvements for EMS should be a target for stroke system redesigns to achieve greater health equity.
ALS diagnosis and survival linked to metals in blood, urine
People with higher levels of metals found in their blood and urine may be more likely to be diagnosed with — and die from — amyotrophic lateral sclerosis, or ALS, a University of Michigan-led study suggests.
Novel Biological Mechanism Discovered That Could Lead to New Treatments for Neurological Disorders, Cancers
The lab of Yongchao C. Ma, PhD, at Stanley Manne Children’s Research Institute at Ann & Robert H. Lurie Children’s Hospital of Chicago discovered a fundamental biological mechanism that could lead to new treatments for neurological diseases, such as spinal muscular atrophy (SMA) and autism, as well as different cancers.
New neurology medication usage low due to high costs, similar effectiveness
While many new medications designed to treat neurologic diseases have hit the market, utilization by patients remains low due to high costs and similar effectiveness to existing drugs, a new study funded by the American Academy of Neurology finds.
Today: ANA2022 Media Roundtable to Spotlight Latest in Neuro Research
As the American Neurological Association’s 147th Annual Meeting wraps up today, October 25, the ANA is holding a Media Roundtable at 11 a.m. U.S. Central for reporters to access the latest developments in neurology and neuroscience.
University of Washington joins industry-academia alliance to accelerate research in neuroscience
The University of Washington has joined the Alliance for Therapies in Neuroscience (ATN), a long-term research partnership between UC San Francisco, UC Berkeley, Genentech (a member of the Roche group) and Roche Holding AG geared to transform the fight against brain diseases and disorders of the central nervous system.
Brain sensor offers Alzheimer’s answers
Scientists have found an explanation for why Alzheimer’s drugs have limited effectiveness and why patients get much worse after going off of them.
How the brain’s inner clock measures seconds
BACKGROUND Tracking the passage of time to the second is critical for motor control, learning and cognition, including the ability to anticipate future events. While the brain depends on its circadian clock to measure hours and days, the circadian clock…
Concussion discovery reveals dire, unknown effects of even mild brain injury
Even mild concussions cause severe and long-lasting impairments in the brain’s ability to clean itself, and this may seed it for Alzheimer’s, dementia and other neurodegenerative problems.
FSU RESEARCHERS LOOK TO NATURAL PRODUCTS TO SHED LIGHT ON PROTEIN INTERACTIONS IN CANCER, NEUROLOGICAL DISEASES
A team of Florida State University researchers from the Department of Chemistry and Biochemistry found that a natural product from the fungus Fusicoccum amygdali stabilizes a family of proteins in the cell that mediate important signaling pathways involved in the pathology of cancer and neurological diseases.
Natural Toxins in the Global Food Supply Continue to Threaten the Health of Underprivileged Communities
Naturally occurring chemicals in the global food supply are known to pose a burden on worldwide health. New studies have found that a certain foodborne toxin, in addition to its known health effects,, is also linked to vaccine resistance, and for the first time the global burden of disease from foodborne arsenic, lead, cadmium, and methyl mercury has been quantified.. The Society for Risk Analysis (SRA) will present new studies as part of its Global Disease Burden Caused by Foodborne Chemicals and Toxins symposium on Monday, Dec. 9 from 1:30-3:00 p.m. as part of its 2019 Annual Meeting at the Crystal Gateway Marriott in Arlington, Virginia. This symposium will provide updates to a 2015 World Health Organization (WHO) publication which analyzed the disease burdens caused by these toxins.
Dial In to the Cutting-edge Neuroscience at ANA2019 during the October 15 Media Roundtable
In a media roundtable at 11 a.m. U.S. Central on Tuesday, October 15, leading neuroscientists will summarize key science being presented at the American Neurological Association’s 2019 Annual Meeting (ANA2019). Reporters may attend in person or dial in.
Microvention Funds $250,000 Educational Grant for the Advancement of Endovascular Education and Technology to the CNS Foundation
MicroVention, one of the world’s fastest growing medical device companies, has granted $250,000 to the Congress of Neurological Surgeons Foundation (CNS Foundation). This generous gift will fund educational programs dedicated toward the advancement of the field of endovascular education and technology.